Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell cycle regulatory proteins in glomerular disease.

S J Shankland1, M Al'Douahji

  • 1Department of Medicine, Division of Nephrology, University of Washington School of Medicine, Seattle, Wash. 98195-6521, USA. stuartjs@u.washington.edu

Experimental Nephrology
|June 3, 1999
PubMed
Summary

Glomerular cell growth, including proliferation, hypertrophy, and apoptosis, is regulated by cell cycle proteins like cyclin-dependent kinases (CDKs) and cyclin kinase inhibitors (CKIs). Targeting these proteins may offer new therapies for glomerular diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Podocyte mitosis - a catastrophe.

Current molecular medicine·2012
Same author

Proteinuria in diabetic kidney disease: a mechanistic viewpoint.

Kidney international·2008
Same author

Darbepoetin alfa protects podocytes from apoptosis in vitro and in vivo.

Kidney international·2007
Same author

Podocyte protection by darbepoetin: preservation of the cytoskeleton and nephrin expression.

Kidney international·2007
Same author

Podocytes in culture: past, present, and future.

Kidney international·2007
Same author

Puromycin aminonucleoside induces oxidant-dependent DNA damage in podocytes in vitro and in vivo.

Kidney international·2006

Area of Science:

  • Nephrology
  • Cell Biology
  • Molecular Medicine

Background:

  • Glomerular cell growth responses vary with disease, involving proliferation, hypertrophy, or apoptosis.
  • Cell cycle regulatory proteins, including cyclin-dependent kinases (CDKs) and cyclin kinase inhibitors (CKIs), control cell growth.
  • Understanding these mechanisms is crucial for developing targeted therapies for kidney diseases.

Purpose of the Study:

  • To elucidate the role of cell cycle regulatory proteins in different glomerular cell growth responses.
  • To identify potential therapeutic targets within the cell cycle machinery for glomerular diseases.

Main Methods:

  • Analysis of cell cycle regulatory proteins (CDKs and CKIs) in various glomerular cell types.
  • Investigating the impact of modulating CDK and CKI activity on cell proliferation, hypertrophy, and apoptosis.

Related Experiment Videos

  • Correlating protein expression and activity with specific disease-induced cellular behaviors.

    • Main Results:

    • CDK2 inhibition reduces mesangial cell proliferation.
    • Decreased CKI levels are necessary for mesangial cell proliferation.
    • Increased CKI levels may inhibit visceral glomerular epithelial cell proliferation and contribute to mesangial cell hypertrophy in diabetes.
    • Increased CDK2 activity may be linked to apoptosis.

    Conclusions:

    • Cell cycle regulatory proteins play distinct roles in mediating glomerular cell responses to disease.
    • Specific CDKs and CKIs are critical regulators of glomerular cell proliferation, hypertrophy, and apoptosis.
    • Targeting these cell cycle proteins presents a promising strategy for future glomerular disease therapies.